Full TextClose
Please select the full text article you wish to view:
Medline ® Abstract for Reference 134
of 'Restless legs syndrome'
134
FDA Announces Voluntary Withdrawal of Pergolide Products. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108877.htm.
no abstract available